{"organizations": [], "uuid": "3be40ec118e5380c13adb26208f5132861320739", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180516.html", "section_title": "Archive News &amp; Video for Wednesday, 16 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-novartis-ceo-looking-hard-at-us-so/brief-novartis-ceo-looking-hard-at-u-s-solid-generics-business-at-sandoz-idUSFWN1SN06B", "country": "US", "domain_rank": 408, "title": "BRIEF-Novartis CEO Looking Hard At U.S. Solid Generics Business At Sandoz", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-16T15:00:00.000+03:00", "replies_count": 0, "uuid": "3be40ec118e5380c13adb26208f5132861320739"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-novartis-ceo-looking-hard-at-us-so/brief-novartis-ceo-looking-hard-at-u-s-solid-generics-business-at-sandoz-idUSFWN1SN06B", "ord_in_thread": 0, "title": "BRIEF-Novartis CEO Looking Hard At U.S. Solid Generics Business At Sandoz", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "novartis ag", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "sandoz", "sentiment": "negative"}, {"name": "alcon", "sentiment": "none"}, {"name": "united states", "sentiment": "none"}, {"name": "sandoz generics", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 16 (Reuters) - Novartis AG:\n* CEO SAYS MADE A MISTAKE, NEED TO GET BETTER AND IMPROVE EVERY ELEMENT OF BUSINESS PARTICULARLY REGAINING TRUST OF SOCIETY\n* CEO SAYS DOING BEST TO BRING CLOSE TO MATTER INVOLVING TRUMP LAWYER CONTRACT\n* CEO SAYS LOOKING AT HOW BEST TO ORGANISE ON INTEGRITY, COMPLIANCE UNDER NEW GENERAL COUNSEL\n* CEO SAYS COMPANY IS NOT GOOD AT SUSTAINABLY MANAGING BROAD DIVERSIFICATION AND INTEGRATING NON-INNOVATIVE MEDICINE ACQUISITIONS, CITING ALCON AND SOME GENERICS INTEGRATIONS\n* CEO SAYS CHALLENGING UPTAKE OF BIOSIMILARS DUE TO STRUCTURE OF U.S. MARKET\n* CEO SAYS LOOKING AT “ALL OPTIONS” FOR SANDOZ GENERICS IN THE UNITED STATES\n* CEO SAYS M&A PRIORITIES ARE BOLT-ONS TO STRENGTHEN ONCOLOGY PIPELINE, STRENGTHEN PHARMACEUTICALS, CELL AND GENE THERAPIES AND DIGITAL AND DATA SCIENCE\n* CEO SAYS MUST GET BETTER AT BOOSTING PERFORMANCE OF LAUNCHES\n* CEO SAYS PLANS TO DEPLOY DATA ANALYTICS SYSTEM TO MONITOR EMAIL TRAFFIC AS PART OF ETHICS PUSH\n* CEO SAYS PHYSICIANS ARE GROWING MORE CONFIDENT IN USING ENTRESTO\n* CEO SAYS ONCOLOGY LAUNCHES HAVE BEEN CHALLENGING, UNDERESTIMATED CHALLENGE FOR KISQUALI IN US\n* CEO SAYS CONTINUES TO BELIEVE KISQUALI IMPORTANT BUT NOT AS LARGE AS ONCE THOUGHT\n* CEO SAYS HOPES TO HAVE AIMOVIG APPROVAL IN COMING WEEKS, HOPES TO BE FIRST TO MARKET WITH MIGRAINE MEDICINE\n* CEO SAYS SEES IMPROVING CHINA GROWTH TREND, SAYS ENVIRONMENT CHANGING AND COUNTRY WANTS TO RAISE BAR ON REGULATORY FRONT WHERE IP IS PROTECTED\n* CEO SAYS BELIEVES CAN SIGNIFICANTLY GROW CHINA BUSINESS, BELIEVES CHINA CAN BECOME PILLAR OF COMPANY\n* CEO SAYS BELIEVES CAN RESOLVE ISSUES SURROUNDING U.S. NEGATIVE DECISION ON RIXATHON BIOSIMILAR FOR MABTHERA\n* CEO SAYS HAS NEW MANDATE TO REDUCE COSTS IN BUSINESS SERVICES THROUGH STRONGER OFFSHORING\n* CEO SAYS DEVELOPING PLAN TO ACCELERATE SAVINGS IN PROCUREMENT, PLANS TO ‘RADICALLY SIMPLIFY SUPPLIER BASE’\n* CEO SAYS “LOOKING HARD” AT U.S. SOLID GENERICS BUSINESS AT SANDOZ Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-16T15:00:00.000+03:00", "crawled": "2018-05-17T14:41:55.024+03:00", "highlightTitle": ""}